Ausubel LJ - Search Results

1

Production of CGMP-Grade Lentiviral Vectors.

Ausubel LJ, Hall C, Sharma A, Shakeley R, Lopez P, Quezada V, Couture S, Laderman K, McMahon R, Huang P, Hsu D, Couture L. Ausubel LJ, et al. Bioprocess Int. 2012 Feb;10(2):32-43. Bioprocess Int. 2012. PMID: 22707919 Free PMC article. No abstract available.

2

GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.

Ausubel LJ, Lopez PM, Couture LA. Ausubel LJ, et al. Methods Mol Biol. 2011;767:147-59. doi: 10.1007/978-1-61779-201-4_11. Methods Mol Biol. 2011. PMID: 21822873

3

Current good manufacturing practice production of an oncolytic recombinant vesicular stomatitis viral vector for cancer treatment.

Ausubel LJ, Meseck M, Derecho I, Lopez P, Knoblauch C, McMahon R, Anderson J, Dunphy N, Quezada V, Khan R, Huang P, Dang W, Luo M, Hsu D, Woo SL, Couture L. Ausubel LJ, et al. Hum Gene Ther. 2011 Apr;22(4):489-97. doi: 10.1089/hum.2010.159. Epub 2011 Mar 8. Hum Gene Ther. 2011. PMID: 21083425 Free PMC article.

4

Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.

Cooper LJ, Ausubel L, Gutierrez M, Stephan S, Shakeley R, Olivares S, Serrano LM, Burton L, Jensen MC, Forman SJ, DiGiusto DL. Cooper LJ, et al. Among authors: ausubel l. Cytotherapy. 2006;8(2):105-17. doi: 10.1080/14653240600620176. Cytotherapy. 2006. PMID: 16698684

5

Functional and molecular comparison of anergic and regulatory T lymphocytes.

Knoechel B, Lohr J, Zhu S, Wong L, Hu D, Ausubel L, Abbas AK. Knoechel B, et al. J Immunol. 2006 Jun 1;176(11):6473-83. doi: 10.4049/jimmunol.176.11.6473. J Immunol. 2006. PMID: 16709804

6

The roles of CD28 and CD40 ligand in T cell activation and tolerance.

Howland KC, Ausubel LJ, London CA, Abbas AK. Howland KC, et al. Among authors: ausubel lj. J Immunol. 2000 May 1;164(9):4465-70. doi: 10.4049/jimmunol.164.9.4465. J Immunol. 2000. PMID: 10779746

7

CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen.

Walker LS, Ausubel LJ, Chodos A, Bekarian N, Abbas AK. Walker LS, et al. Among authors: ausubel lj. J Immunol. 2002 Dec 1;169(11):6202-9. doi: 10.4049/jimmunol.169.11.6202. J Immunol. 2002. PMID: 12444125

8

Functional tolerance is maintained despite proliferation of CD4 T cells after encounter with tissue-derived antigen.

Ausubel LJ, Chodos A, Bekarian N, Abbas AK, Walker LS. Ausubel LJ, et al. Dev Immunol. 2002 Sep;9(3):173-6. doi: 10.1080/1044667031000137656. Dev Immunol. 2002. PMID: 12885158 Free PMC article.

9

Weak peptide agonists reveal functional differences in B7-1 and B7-2 costimulation of human T cell clones.

Anderson DE, Ausubel LJ, Krieger J, Höllsberg P, Freeman GJ, Hafler DA. Anderson DE, et al. Among authors: ausubel lj. J Immunol. 1997 Aug 15;159(4):1669-75. J Immunol. 1997. PMID: 9257827

10

Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells.

Höllsberg P, Wucherpfennig KW, Ausubel LJ, Calvo V, Bierer BE, Hafler DA. Höllsberg P, et al. Among authors: ausubel lj. J Immunol. 1992 May 15;148(10):3256-63. J Immunol. 1992. PMID: 1374452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters